[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100619890":3},{"organization":4,"armGroups":7,"interventions":23,"overallOfficials":35,"centralContacts":43,"locations":49,"responsibleParty":94,"collaborators":10,"id":96,"slug":97,"hasResults":98,"nctId":99,"briefTitle":100,"officialTitle":101,"acronym":102,"eligibilityCriteria":103,"healthyVolunteers":98,"sex":104,"minAge":105,"maxAge":10,"enrollmentInfo":106,"targetDuration":10,"studyType":109,"phases":10,"briefSummary":110,"conditions":111,"keywords":114,"overallStatus":52,"whyStopped":10,"lastUpdateSubmitDate":121,"lastUpdatePostDateStruct":122,"startDateStruct":125,"completionDateStruct":127,"leadSponsor":129,"locationsCount":130},{"fullName":5,"class":6},"Imperative Care, Inc.","INDUSTRY",[8,14,19],{"label":9,"type":10,"description":11,"interventionNames":12},"Peripheral Arterial",null,"Subjects in this cohort will undergo aspiration thrombectomy to remove thrombus from the peripheral arterial vasculature",[13],"Device: Prodigy Thrombectomy System",{"label":15,"type":10,"description":16,"interventionNames":17},"Peripheral Venous","Subjects in this cohort will undergo aspiration thrombectomy to remove thrombus from the peripheral venous vasculature",[18],"Device: Symphony Thrombectomy System",{"label":20,"type":10,"description":21,"interventionNames":22},"Pulmonary Embolism","Subjects in this cohort will undergo aspiration thrombectomy to remove thrombus from the pulmonary vasculature",[18],[24,29,32],{"type":25,"name":26,"description":27,"armGroupLabels":28,"otherNames":10},"DEVICE","Prodigy Thrombectomy System","Removal of thrombus\u002Femboli from blood vessels in the peripheral vasculature",[9],{"type":25,"name":30,"description":27,"armGroupLabels":31,"otherNames":10},"Symphony Thrombectomy System",[15],{"type":25,"name":30,"description":33,"armGroupLabels":34,"otherNames":10},"Removal of thrombus\u002Femboli from the pulmonary vasculature",[20],[36,40],{"name":37,"affiliation":38,"role":39},"Steven Abramowitz, MD","Medstar Health Research Institute","PRINCIPAL_INVESTIGATOR",{"name":41,"affiliation":42,"role":39},"Maya Serhal, MD","Massachusetts General Hospital",[44],{"name":45,"role":46,"phone":47,"phoneExt":10,"email":48},"Sylvie Akiel-Fu, MPH","CONTACT","917-375-4735","safu@imperativecare.com",[50,64,74,84],{"facility":51,"status":52,"city":53,"state":54,"zip":55,"country":56,"countryCode":57,"cosmosGeoPoint":58,"geoPoint":63,"contacts":10},"Huntsville Hospital","RECRUITING","Huntsville","Alabama","35801","United States","US",{"type":59,"coordinates":60},"Point",[61,62],-86.58594,34.7304,{"lat":62,"lon":61},{"facility":65,"status":52,"city":66,"state":67,"zip":68,"country":56,"countryCode":57,"cosmosGeoPoint":69,"geoPoint":73,"contacts":10},"BayCare Health - St. Joseph Hospital","Tampa","Florida","33607",{"type":59,"coordinates":70},[71,72],-82.45843,27.94752,{"lat":72,"lon":71},{"facility":75,"status":52,"city":76,"state":77,"zip":78,"country":56,"countryCode":57,"cosmosGeoPoint":79,"geoPoint":83,"contacts":10},"Profound Research","Munster","Illinois","46321",{"type":59,"coordinates":80},[81,82],-88.90285,41.10559,{"lat":82,"lon":81},{"facility":85,"status":52,"city":86,"state":87,"zip":88,"country":56,"countryCode":57,"cosmosGeoPoint":89,"geoPoint":93,"contacts":10},"Mercy Health","Cincinnati","Ohio","45242",{"type":59,"coordinates":90},[91,92],-84.51439,39.12711,{"lat":92,"lon":91},{"type":95,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100619890","aspiration-thrombectomy-using-the-symphony-or-prodigy-system-100619890",false,"NCT07350499","Aspiration Thrombectomy Using the Symphony or Prodigy System","Long-Term CLinical Evaluation of Aspiration ThRombectomy Using the Symphony or ProdIgy Thrombectomy System - CLEAR-IT","CLEAR-IT","Inclusion Criteria:\n\n1. Subject is ≥ 18 years of age\n2. Subject is willing and able to comply with the follow-up schedule specified in this protocol\n3. Subject is willing and able to provide written informed consent prior to any study-related data collection\n4. Subject has a planned procedure, involving the use of Imperative Care vascular devices within their intended use\n\nExclusion Criteria:\n\n1. Subjects with any contraindications per the applicable Instructions for Use\n2. Subject with life expectancy of less than 1 year\n3. In the opinion of the Investigator, the patient is not a suitable candidate for intervention with Imperative Care devices\n4. Subject who may be unable to complete study follow-up\n5. Peripheral Venous Cohort ONLY: Presence of thrombus extending more than 2 cm into the IVC on imaging","ALL","18 Years",{"count":107,"type":108},750,"ESTIMATED","OBSERVATIONAL","The study is designed to evaluate the short-term and long-term clinical performance and safety of the Symphony and Prodigy thrombectomy systems used in endovascular procedures across the peripheral or pulmonary vasculature.",[112,113,20],"Arterial Thromboembolism","Venous Thromboembolism",[20,115,116,117,118,119,120],"Thrombus","Thromboembolism","Aspiration","Aspiration thrombectomy","Anticoagulation","Peripheral vasculature","2026-06-23",{"date":123,"type":124},"2026-06-26","ACTUAL",{"date":126,"type":124},"2026-02-13",{"date":128,"type":108},"2030-09",{"name":5,"class":6},4]